162 related articles for article (PubMed ID: 32566575)
1. Second primary malignancies among cancer patients.
Zheng X; Li X; Wang M; Shen J; Sisti G; He Z; Huang J; Li YM; Wu A;
Ann Transl Med; 2020 May; 8(10):638. PubMed ID: 32566575
[TBL] [Abstract][Full Text] [Related]
2. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract][Full Text] [Related]
3. Standardized Incidence Rate, Risk and Survival Outcomes of Second Primary Malignancy Among Renal Cell Carcinoma Survivors: A Nested Case-Control Study.
Wang Z; Yin Y; Wang J; Zhu Y; Li X; Zeng X
Front Oncol; 2021; 11():716741. PubMed ID: 34395291
[TBL] [Abstract][Full Text] [Related]
4. Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States.
Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
Int J Cancer; 2019 Jul; 145(1):143-153. PubMed ID: 30613963
[TBL] [Abstract][Full Text] [Related]
5. Better Prognosis and Survival in Esophageal Cancer Survivors After Comorbid Second Primary Malignancies: A SEER Database-Based Study.
Ye J; Hu S; Zhang W; Zhang D; Zhang Y; Yu D; Peng J; Xu J; Wei Y
Front Surg; 2022; 9():893429. PubMed ID: 35769151
[TBL] [Abstract][Full Text] [Related]
6. Second Primary Malignancy Risk in Multiple Myeloma from 1975 to 2018.
Wang J; Lv C; Zhou M; Xu JY; Chen B; Wan Y
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230842
[TBL] [Abstract][Full Text] [Related]
7. The risk and prognosis of secondary primary malignancy in lung cancer: a population-based study.
Hong J; Wei R; Nie C; Leonteva A; Han X; Du X; Wang J; Zhu L; Tian W; Zhou H
Future Oncol; 2021 Nov; 17(33):4497-4509. PubMed ID: 34402680
[TBL] [Abstract][Full Text] [Related]
8. Increased incidence of second primary malignancy in patients with malignant astrocytoma: a population-based study.
Wang W
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138756
[TBL] [Abstract][Full Text] [Related]
9. Impact of latency time on survival for adolescents and young adults with a second primary malignancy.
Goldfarb M; Rosenberg AS; Li Q; Keegan THM
Cancer; 2018 Mar; 124(6):1260-1268. PubMed ID: 29205296
[TBL] [Abstract][Full Text] [Related]
10. Long-term radiation therapy-related risk of second primary malignancies in patients with lung cancer.
Han C; Wu Y; Kang K; Wang Z; Liu Z; Zhang F
J Thorac Dis; 2021 Oct; 13(10):5863-5874. PubMed ID: 34795935
[TBL] [Abstract][Full Text] [Related]
11. Exploring the risk of second primary malignancies in laryngeal cancer survivors: insights from the SEER database.
Afify AY; Ashry MH
Eur Arch Otorhinolaryngol; 2024 May; ():. PubMed ID: 38775833
[TBL] [Abstract][Full Text] [Related]
12. Risk and survival of second primary malignancies following diagnosis of gastric mucosa-associated lymphoid tissue lymphomas: A population-based study.
Yang Y; Yang Y; Yan S
Curr Probl Cancer; 2021 Dec; 45(6):100735. PubMed ID: 33867153
[TBL] [Abstract][Full Text] [Related]
13. Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors.
Keegan THM; Bleyer A; Rosenberg AS; Li Q; Goldfarb M
JAMA Oncol; 2017 Nov; 3(11):1554-1557. PubMed ID: 28426850
[TBL] [Abstract][Full Text] [Related]
14. Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States.
Saltus CW; Vassilev ZP; Zong J; Calingaert B; Andrews EB; Soriano-Gabarró M; Kaye JA
Prostate Cancer; 2019; 2019():4387415. PubMed ID: 30886751
[TBL] [Abstract][Full Text] [Related]
15. Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis.
Jia H; Li Q; Yuan J; Sun X; Wu Z
Oncologist; 2020 Apr; 25(4):e644-e650. PubMed ID: 31943509
[TBL] [Abstract][Full Text] [Related]
16. Trends of Second Primary Malignancy in Patients with Thyroid Cancer: A Population-Based Cohort Study in Israel.
Izkhakov E; Barchana M; Liphshitz I; Silverman BG; Stern N; Keinan-Boker L
Thyroid; 2017 Jun; 27(6):793-801. PubMed ID: 28338430
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Diabetes Mellitus on the Second Primary Malignancies in Colorectal Cancer Patients.
Halamkova J; Kazda T; Pehalova L; Gonec R; Kozakova S; Bohovicova L; Slaby O; Demlova R; Svoboda M; Kiss I
Front Oncol; 2020; 10():573394. PubMed ID: 33585194
[TBL] [Abstract][Full Text] [Related]
18. Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).
Jung YS; Lim J; Jung KW; Ryu J; Won YJ
PLoS One; 2015; 10(7):e0134160. PubMed ID: 26218068
[TBL] [Abstract][Full Text] [Related]
19. Differential Second Primary Malignancy Occurrence After Breast Cancer According to HER2 Status: A Population-Based Study.
Lin X; Lin X; Li Y; Zhang Y; Lin J; Zhang G
Int J Gen Med; 2021; 14():8775-8784. PubMed ID: 34853531
[TBL] [Abstract][Full Text] [Related]
20. Second primary malignancy in patients with cholangiocarcinoma: a population-based study.
Zhuang L; Yan X; Meng Z
Cancer Manag Res; 2019; 11():1969-1983. PubMed ID: 30881122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]